CN Patent

CN117304179A — 杰克替尼二盐酸盐一水合物的制备工艺

Assigned to Suzhou Zelgen Biopharmaceutical Co Ltd · Expires 2023-12-29 · 2y expired

What this patent protects

本发明涉及高纯度杰克替尼二盐酸盐一水合物(式(A)化合物)的制备方法。整个工艺方法不含特殊反应条件和复杂后处理工序、原料和试剂来源易得、转化率高、环境友好，非常适合工业化生产。

USPTO Abstract

本发明涉及高纯度杰克替尼二盐酸盐一水合物(式(A)化合物)的制备方法。整个工艺方法不含特殊反应条件和复杂后处理工序、原料和试剂来源易得、转化率高、环境友好，非常适合工业化生产。

Drugs covered by this patent

momelotinib-dihydrochloride (MOMELOTINIB DIHYDROCHLORIDE)

Patent Metadata

Patent number: CN117304179A
Jurisdiction: CN
Classification: —
Expires: 2023-12-29
Drug substance claim: No
Drug product claim: No
Assignee: Suzhou Zelgen Biopharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.